Market: NASD |
Currency: USD
Address: 360 Massachusetts Avenue
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Show more
📈 Bluejay Diagnostics, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
25-50%
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
2024 |
- |
$0.020000 |
- |
2024-11-18 |
- |
Stock split |
$0.125000 |
- |
2024-06-20 |
- |
Stock split |
Total Amount for 2024: $0.145000 |
2023 |
- |
$0.050000 |
- |
2023-07-24 |
- |
Stock split |
Total Amount for 2023: $0.050000 |
📅 Earnings & EPS History for Bluejay Diagnostics, Inc.
Date | Reported EPS |
---|
2024-03-28 | -712 |
2023-11-09 | -832 |
2023-08-14 | -1100 |
📰 Related News & Research
No related articles found for "bluejay diagnostics".